Imunon Reports Promising Phase 2 Ovarian Cancer Trial ResultsCompany Announcements Imunon Reports Promising Phase 2 Ovarian Cancer Trial Results

[cafead]

via Imunon, Inc. has revealed encouraging results from its Phase 2 OVATION 2 trial, which tested IMNN-001 alongside standard chemotherapy treatments for advanced ovarian cancer. The data indicates that the treatment could potentially extend the median time to event and improve overall survival rates, although statistical significance was not reached

article source